Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer
מצבים רפואיים
Epithelial Ovarian Cancer · Ovarian Cancer · Fallopian Tube Cancer · Primary Peritoneal Carcinoma
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Advent Health, Orlando, Florida, United States
Contact: Principal Investigator (Robert Holloway, MD)Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States
Contact: Principal Investigator (Melissa Geller, M.D.)Washington University School of Medicine in St. Louis, St Louis, Missouri, United States
Contact: Principal Investigator (Andrea Hagemann, MD)Providence Cancer Institute, Portland, Oregon, United States
Contact: Principal Investigator (Christopher Darus, MD)Sanford Health, Sioux Falls, South Dakota, United States
Contact: Principal Investigator (Maria Bell, MD)Erlanger Health, Chattanooga, Tennessee, United States
Contact: Principal Investigator (Stephen DePasquale, MD)Providence Sacred Heart Medical Center & Children's Hospital, Spokane, Washington, United States
Contact: Principal Investigator (Melanie Bergman, MD)Froedtert and The Medical College of Wisconsin, Milwaukee, Wisconsin, United States
Contact: Principal Investigator (William Bradley, MD)
מובילי המחקר
Premal H Thaker, M.D.
Study Chair
Washington University School of Medicine